Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Patent
1995-09-13
1997-07-08
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
514546, 560263, A61K 31215
Patent
active
056458525
ABSTRACT:
This invention provides a method of inducing cell differentiation in a subject and methods of treating leukemia, thalassemia, or sickle cell anemia by administration to the subject of one or more oral bolus doses of a pharmaceutical composition comprising an effective amount of one or more butyryl glycerides and a pharmaceutically acceptable carrier. This invention also provides a method of treating a surface or skin disorder in a subject by topical administration to the subject of a pharmaceutical composition comprising an effective amount of one or more butyryl glycerides and a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4816450 (1989-03-01), Bell
patent: 5025029 (1991-06-01), Perrine
patent: 5185436 (1993-02-01), Villa et al.
patent: 5200553 (1993-04-01), Nudelman et al.
patent: 5258197 (1993-11-01), Wheeler
Wilkinson JBC 268 #4, p. 2844, Feb. 1993.
Deschner, E.E., et al., Cancer Letters, 52: 79-82, 1990.
Lea, M.A., et al., Anticancer Research, 13: 145-150, 1993.
Boffa, L.C., et al., Cancer Research, 52: 5906-5912, Nov. 1, 1992.
Planchon, P. et al., J. Pharm. Sci., 82: 1046-1048, Oct. 1993.
Perrine, S.P., et al., Experientia, Birkhauser Verlag Basel, 49: 133-137, 1993.
Blau, C.A., et al., Blood, 81: 529-537, Jan. 1993.
Daniel, P., et al., Clinica Chimica Acta, 181: 255-264, 1985.
Perrine, S.P., et al., New Eng. J. Med., 328: 81-86, Jan. 1993.
Miller A. et al., Eur. J. Cancer Clin. Oncol., 23: 1283-1287, 1987.
Novogrodsky, A. et al., Cancer, 51: 9-14, Jan. 1993.
Kishore Gollamudi S.
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Butyric ester cyto-differtiating agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Butyric ester cyto-differtiating agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Butyric ester cyto-differtiating agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2407631